164 related articles for article (PubMed ID: 25163814)
1. LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Lee TF; Liou MH; Huang YJ; Chao PJ; Ting HM; Lee HY; Fang FM
Sci Rep; 2014 Aug; 4():6217. PubMed ID: 25163814
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy.
Lee TF; Fang FM
Radiother Oncol; 2013 Mar; 106(3):352-8. PubMed ID: 23333019
[TBL] [Abstract][Full Text] [Related]
3. Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.
Lee TF; Liou MH; Ting HM; Chang L; Lee HY; Wan Leung S; Huang CJ; Chao PJ
Sci Rep; 2015 Aug; 5():13165. PubMed ID: 26289304
[TBL] [Abstract][Full Text] [Related]
4. Using multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of Xerostomia after intensity-modulated radiotherapy for head and neck cancer.
Lee TF; Chao PJ; Ting HM; Chang L; Huang YJ; Wu JM; Wang HY; Horng MF; Chang CM; Lan JH; Huang YY; Fang FM; Leung SW
PLoS One; 2014; 9(2):e89700. PubMed ID: 24586971
[TBL] [Abstract][Full Text] [Related]
5. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.
Sommat K; Hussain A; Ong WS; Yit NLF; Khoo JBK; Soong YL; Wee JTS; Fong KW; Tan TWK
Radiother Oncol; 2019 Sep; 138():149-157. PubMed ID: 31265972
[TBL] [Abstract][Full Text] [Related]
6. Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia.
Yahya N; Linge A; Leger K; Maile T; Kemper M; Haim D; Jöhrens K; Troost EGC; Krause M; Löck S
Acta Oncol; 2022 Jul; 61(7):856-863. PubMed ID: 35657056
[TBL] [Abstract][Full Text] [Related]
7. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.
Yang K; Xie W; Zhang X; Wang Y; Shou A; Wang Q; Tian J; Yang J; Li G
Aging (Albany NY); 2021 Jul; 13(14):18645-18657. PubMed ID: 34282056
[TBL] [Abstract][Full Text] [Related]
8. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
[TBL] [Abstract][Full Text] [Related]
9. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
10. Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma.
Lastrucci L; Bertocci S; Bini V; Borghesi S; De Majo R; Rampini A; Pernici P; Gennari PG
Radiol Med; 2017 Apr; 122(4):303-308. PubMed ID: 28070838
[TBL] [Abstract][Full Text] [Related]
11. Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
Pan XB; Liu Y; Huang ST; Chen KH; Jiang YM; Zhu XD
Medicine (Baltimore); 2019 Sep; 98(36):e17030. PubMed ID: 31490391
[TBL] [Abstract][Full Text] [Related]
12. A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique.
Teng F; Fan W; Luo Y; Xu S; Gong H; Ge R; Zhang X; Wang X; Ma L
Front Oncol; 2021; 11():633556. PubMed ID: 33718219
[TBL] [Abstract][Full Text] [Related]
13. Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.
Buchapudi RR; Manickam R; M R AK; C R TP; Chandraraj V; Pyakuryal A; Narayanasamy G
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2463-2470. PubMed ID: 31450921
[TBL] [Abstract][Full Text] [Related]
14. Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study.
Huang H; Miao J; Xiao X; Hu J; Zhang G; Peng Y; Lu S; Liang Y; Huang S; Han F; Deng X; Zhao C; Wang L
Radiother Oncol; 2022 Oct; 175():1-9. PubMed ID: 35817320
[TBL] [Abstract][Full Text] [Related]
15. Clinical observation of submandibular gland transfer for the prevention of xerostomia after radiotherapy for nasopharyngeal carcinoma: a prospective randomized controlled study of 32 cases.
Zhang X; Liu F; Lan X; Yu L; Wu W; Wu X; Xiao F; Li S
Radiat Oncol; 2014 Feb; 9():62. PubMed ID: 24555575
[TBL] [Abstract][Full Text] [Related]
16. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
Luo R; Wu VWC; He B; Gao X; Xu Z; Wang D; Yang Z; Li M; Lin Z
BMC Cancer; 2018 May; 18(1):575. PubMed ID: 29776390
[TBL] [Abstract][Full Text] [Related]
17. A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy.
Li M; Zhang J; Zha Y; Li Y; Hu B; Zheng S; Zhou J
BMC Oral Health; 2022 Jun; 22(1):239. PubMed ID: 35715856
[TBL] [Abstract][Full Text] [Related]
18. Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Pan XB; Liu Y; Li L; Qu S; Chen L; Liang SX; Chen KH; Liang ZG; Zhu XD
Aging (Albany NY); 2020 Jan; 12(2):1857-1866. PubMed ID: 32005029
[TBL] [Abstract][Full Text] [Related]
19. Helical tomotherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT.
Murthy V; Master Z; Gupta T; Ghosh-Laskar S; Budrukkar A; Phurailatpam R; Agarwal J
J Cancer Res Ther; 2010; 6(2):194-8. PubMed ID: 20622367
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
